Clinical roundtable Oncology

Come with ideas. Leave with practical insights.
The rapid evolution of precision medicine, the buzz around CAR-T therapies, and the promise of biosimilars. Trends like these can really impact your mission of ensuring quality, affordable cancer care. How do you know which ones need your attention?

Collaborative, topical, and in-depth, our complimentary clinical roundtables power your team with practical insights your plan can use to respond to emerging developments in cancer care.

During your oncology clinical roundtable, you’ll work side by side with members of our oncology clinical leadership and:

  • Explore the nuances of the latest oncology trends affecting your plan
  • Assess trends’ effects on your approach to managing cancer care
  • Brainstorm strategies to address these developments

We can conduct roundtables in person or online.

Who should attend

  • Chief medical directors
  • Medical directors
  • Network strategy leaders
  • Affordability of care leaders

Request your complimentary roundtable

Our oncology clinical leaders

Robert Mandel, MD, MBA


Michael J. Fisch, MD, MPH, FACP, FAAHPM, FASCO

National Medical Director, Medical Oncology Programs and Genetics

Stacey Ban, MD

Vice President and Medical Director, Oncology

Robert P. Zimmerman, MD

National Medical Director, Radiation Oncology

Chris Buckle, MD, MBA, FRCPC

Associate Chief Medical Officer and National Medical Director, Radiology and Guideline Development

How it works


Sign up for your roundtable


We’ll contact you to schedule the roundtable for a time that works best for you. We’ll also ask you for any topics or trends that you want to dive into with us.


Members from our clinical oncology leadership will conduct the roundtable with you.